IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity

被引:22
作者
Hue, J
Kim, A
Song, H
Choi, I
Park, H
Kim, T
Lee, WJ
Kang, H
Cho, D
机构
[1] Sookmyung Womens Univ, Dept Life Sci, Seoul, South Korea
[2] Sookmyung Womens Univ, Coll Pharm, Seoul, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Immunol Lab, Seoul, South Korea
[4] Catholic Univ, Dept Dermatol, St Marys Hosp, Seoul, South Korea
[5] Chonnam Natl Univ, Coll Pharm, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Anat & Tumor Immunity, Med Res Ctr, Seoul, South Korea
[7] Chonnam Natl Univ, Sch Biol Sci & Technol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
IL-18; SCF melanoma; ROI; p38; MAPK;
D O I
10.1016/j.imlet.2004.08.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been reported that interleukin-18 (IL-18) is secreted by B16 murine melanoma cells and that this endogenous IL-18 is involved in the immune escape of murine melanoma cells. The present study investigated whether interleukin (IL)-18 can regulate stem cell factor (SCF) expression, known to be associated with melanocyte proliferation, in B16F10 murine melanoma cells. SCF expression was examined by RT-PCR, intracellular FACS analysis, and ELISA in IL-18 antisense transfectants. Transfection with IL-18 antisense cDNA reduced SCF expression and the expression was enhanced by addition of exogenous IL-18. In addition, the effect of IL-18 was blocked by the antioxidant, N-acetyl-L-cysteine (NAC), indicating that IL-18 regulates ROI production, which is involved in SCF production. Furthermore, inhibitors of p38 mitogen-activated protein kinase (MAPK), such as SB203580, blocked enhanced SCF expression, indicating that p38 MAPK activity is required for IL-18-enhanced SCF production. Taken together, these results suggest that IL-18 plays a critical role as a regulatory factor of SCF expression via ROI and p38 MAPK activity in B16F10 murine melanoma cells. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 42 条
[1]  
BAR EM, 1997, J CELL PHYSL, V173, P275
[2]   EXPRESSION OF STEM-CELL FACTOR AND ITS RECEPTOR BY HUMAN NEUROBLASTOMA-CELLS AND TUMORS [J].
BECK, D ;
GROSS, N ;
BROGNARA, CB ;
PERRUISSEAU, G .
BLOOD, 1995, 86 (08) :3132-3138
[3]  
Bellone G, 1997, J CELL PHYSIOL, V172, P1, DOI 10.1002/(SICI)1097-4652(199707)172:1<1::AID-JCP1>3.0.CO
[4]  
2-S
[5]  
Boehme SA, 1999, J IMMUNOL, V163, P1611
[6]   Stem cell factor and hematopoiesis [J].
Broudy, VC .
BLOOD, 1997, 90 (04) :1345-1364
[7]  
Cho D, 2000, CANCER RES, V60, P2703
[8]   Superoxide anion is a natural inhibitor of Fas-mediated cell death [J].
Clement, MV ;
Stamenkovic, I .
EMBO JOURNAL, 1996, 15 (02) :216-225
[9]   Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo [J].
Costa, JJ ;
Demetri, GD ;
Harrist, TJ ;
Dvorak, AM ;
Hayes, DF ;
Merica, EA ;
Menchaca, DM ;
Gringeri, AJ ;
Schwartz, LB ;
Galli, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2681-2686
[10]   Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway [J].
Foltz, IN ;
Lee, JC ;
Young, PR ;
Schrader, JW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3296-3301